School of Pharmacy, University of Reading, Reading, UK.
Int J Pharm. 2010 May 31;391(1-2):162-8. doi: 10.1016/j.ijpharm.2010.03.014. Epub 2010 Mar 7.
This study probes the molecular interactions between model drugs and poloxamers that facilitate dissolution rate improvements using solid dispersions. Ibuprofen and ketoprofen solid dispersions were prepared at different mole ratios using poloxamers 407 and 188. The carbonyl stretching vibration of the ibuprofen dimer shifted to higher wavenumber in the infrared spectra of 2:1 drug:carrier mole ratio solid dispersions, indicating disruption of the ibuprofen dimer concomitant with hydrogen bond formation between the drug and carrier. Solid dispersions with mole ratios >2:1 drug:carrier (up to 29:1) showed both ibuprofen hydrogen-bonded to the poloxamer, and excess drug present as dimers. X-ray diffraction studies confirmed these findings with no evidence of crystalline drug in 2:1 mole ratio systems whereas higher drug loadings retained crystalline ibuprofen. Similar results were found with ketoprofen-poloxamer solid dispersions. Thermal analysis of ibuprofen-poloxamer 407 solid dispersions and their resultant phase diagram suggested solid solutions and a eutectic system were formed, depending on drug loading. Dissolution studies showed fastest release from the solid solutions; dissolution rates from solid solutions were 12-fold greater than the dissolution of ibuprofen powder whereas the eutectic system gave a 6-fold improvement over the powder. When designing solid dispersions to improve the delivery of poorly-water soluble drugs, the nature of drug:carrier interactions, which are governed by the stochiometry of the composition, can affect the dissolution rate improvement.
本研究探讨了模型药物与泊洛沙姆之间的分子相互作用,这些相互作用通过固体分散体促进了溶出速率的提高。采用泊洛沙姆 407 和 188 以不同的摩尔比制备了布洛芬和酮洛芬的固体分散体。红外光谱中,布洛芬二聚体的羰基伸缩振动向高波数移动,表明布洛芬二聚体的破坏伴随着药物和载体之间氢键的形成。摩尔比大于 2:1 药物:载体(高达 29:1)的固体分散体显示布洛芬与泊洛沙姆氢键结合,并且存在过量的二聚体药物。X 射线衍射研究证实了这些发现,在 2:1 摩尔比体系中没有发现结晶药物,而较高的药物载量保留了结晶布洛芬。酮洛芬-泊洛沙姆固体分散体也得到了类似的结果。布洛芬-泊洛沙姆 407 固体分散体的热分析及其相图表明,形成了固溶体和共晶体系,这取决于药物负载。溶出研究表明,固溶体的释放最快;固溶体的溶出速率是布洛芬粉末的 12 倍,而共晶体系的溶出速率比粉末提高了 6 倍。在设计用于改善难溶性药物传递的固体分散体时,药物与载体之间的相互作用的性质受组成的化学计量学控制,这会影响溶出速率的提高。